Sichuan Biokin PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Sichuan Biokin PharmaceuticalLtd has a total shareholder equity of CN¥5.2B and total debt of CN¥748.8M, which brings its debt-to-equity ratio to 14.5%. Its total assets and total liabilities are CN¥6.9B and CN¥1.7B respectively. Sichuan Biokin PharmaceuticalLtd's EBIT is CN¥4.4B making its interest coverage ratio -6298. It has cash and short-term investments of CN¥5.8B.
Key information
14.5%
Debt to equity ratio
CN¥748.80m
Debt
Interest coverage ratio | -6298x |
Cash | CN¥5.83b |
Equity | CN¥5.16b |
Total liabilities | CN¥1.72b |
Total assets | CN¥6.87b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 688506's short term assets (CN¥6.2B) exceed its short term liabilities (CN¥1.6B).
Long Term Liabilities: 688506's short term assets (CN¥6.2B) exceed its long term liabilities (CN¥99.9M).
Debt to Equity History and Analysis
Debt Level: 688506 has more cash than its total debt.
Reducing Debt: 688506's debt to equity ratio has reduced from 51.8% to 14.5% over the past 5 years.
Debt Coverage: 688506's debt is well covered by operating cash flow (661.3%).
Interest Coverage: 688506 earns more interest than it pays, so coverage of interest payments is not a concern.